Edit |   |
---|---|
Antigenic Specificity | CD56, Human (Lorvotuzumab biosimilar) |
Clone | Lorvotuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD56 Recombinant Antibody. Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate. It comprises the CD56-binding antibody, lorvotuzumab (huN901), with a maytansinoid cell-killing3 KB (178 words) - 17:21, 7 March 2021. |
Immunogen | n/a |
Other Names | Anti-CD56 Recombinant Antibody, Research Grade Lorvotuzumab, Anti-Human CD56 Recombinant Antibody, BB-10901, IMGN901, huN901-DM1, Antibody Drug Analogues, Monoclonal Antibody, YR1026, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1008106-64-6 |
Catalog # | YR1026 |
Price | please inquire |
Order / More Info | CD56, Human (Lorvotuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |